Volume 9, Issue 2 (June 2024)                   J Environ Health Sustain Dev 2024, 9(2): 2257-2269 | Back to browse issues page

Ethics code: IR.TBZMED.VCR.REC.1401.119

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abouee Mehrizi O, Ghadiri S K, Anvari F, Mehnati P. Removal of Fexofenadine and Montelukast Drugs from Aquatic Environment Using a Rhodotron Accelerator. J Environ Health Sustain Dev 2024; 9 (2) :2257-2269
URL: http://jehsd.ssu.ac.ir/article-1-709-en.html
Radiation Medical Sciences Research Center, Department of Medical Physics, Tabriz University of Medical Sciences, Tabriz Iran
Abstract:   (76 Views)
Introduction: Nowadays, the management of drug effluents, as emerging pollutants, has attracted great attention due to human health and ecological adverse effects. During the COVID-19 pandemic, two drugs, Fexofenadine and Montelukast, have been used in large quantities for patients with lung involvement. The aim of this study is to investigate the feasibility of removing Fexofenadine and Montelukast and determine the removal kinetics.
Material and Methods: In this study, we used Rhodotron accelerator to determine kinetic coefficients for the removal of drugs. Our research focused on studying the kinetics of E-Beam radiation reactions and the generation of significant amounts of free radicals during these processes. We employed first-order and second-order kinetic models under laboratory conditions, taking into account various influencing factors to establish the rate of removal.
Results: The results showed that the decomposition of Fexofenadine and Montelukast drugs by high-energy E-Beam bending process is a pseudo-first-order reaction with a coefficient of more than 0.9105 and 0.998, respectively. The results showed that the reaction rate constant depended significantly on the initial concentration of Fexofenadine and Montelukast drugs and their molecular structure.
Conclusion: Using a Rhodotron accelerator is important for removing Fexofenadine and Montelukast from the aquatic environment.
Full-Text [PDF 1101 kb]   (45 Downloads) |   |   Full-Text (HTML)  (36 Views)  
Type of Study: Original articles | Subject: Environmental pollution
Received: 2024/02/23 | Accepted: 2024/05/20 | Published: 2024/06/26

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Journal of Environmental Health and Sustainable Development

Designed & Developed by : Yektaweb